|
Real-time Estimate
Tradegate
10:38:36 26/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 80.58 EUR | -0.28% |
|
+1.90% | +26.63% |
| 10/08 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
| 10/08 | Orion partner's phase 3 study with levosimendan missed its goals | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq Helsinki
ORNBV 80.60 €
-0.25%
1.46M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Helsinki
| ORNBV | 80.60EUR | -0.25% | 1.46M € | |
CBOE
| ORNBVh | 80.60EUR | -0.31% | 963K € | |
|
Tradegate
| OFK | 80.80EUR | -0.06% | 1.37K € | |
|
Deutsche Boerse AG
| OFK | 80.70EUR | +2.02% | 0 € | |
|
London S.E.
| 0M2O | 80.75EUR | -0.15% | 0 € | |
|
CBOE
| 0M2O | 78.80EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| OFK | 80.65EUR | -0.06% | 0 € | |
|
Boerse Muenchen
| OFK | 80.65EUR | -0.19% | 0 € | |
|
Berne S.E.
| OFK | 75.38CHF | +1.81% | 0 CHF | |
|
Borsa Italiana
| 1ORNBV | 80.60EUR | +1.83% | 0 € | |
Nasdaq Helsinki
| ORNAV | 80.50EUR | 0.00% | 124K € | |
|
CBOE
| ORNAVh | 80.40EUR | -0.25% | 2.49K € | |
|
CBOE
| 0M2N | 63.25EUR | 0.00% | 0 € | |
|
Deutsche Boerse AG
| OFKB | 79.50EUR | +1.92% | 0 € | |
Deutsche Boerse AG
| OFK0 | 40.20EUR | +2.03% | 0 € | |
|
OTC Markets
| ORINY | 43.02USD | +2.20% | 27.32K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 82.25 | 82.25 | 81.5 |
| Spread/Res. | -2.01% | -2.01% | -1.10% |
| Spread/Supp. | +7.18% | +11.71% | +19.67% |
| Support | 75.2 | 72.15 | 67.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
Select your edition
All financial news and data tailored to specific country editions
